Risk Factors and Predictive Model for Inflammatory Polyps in Ureteral Stones
UROLITH-POLYP
Risk Factors and Development of a Predictive Model for Stone-Associated Inflammatory Ureteral Polyps: A Retrospective Cohort Study With Prospective Validation
1 other identifier
observational
300
1 country
1
Brief Summary
This is a single-center, observational study including a retrospective cohort and a prospective validation cohort. The study aims to identify independent risk factors for inflammatory ureteral polyps in patients with ureteral calculi and develop a preoperative predictive model. The retrospective part will analyze clinical and imaging data of patients treated at the First Hospital of Jilin University between 2018 and 2025. The prospective part is currently recruiting participants to validate the model. The primary outcome is the intraoperative diagnosis of inflammatory ureteral polyps.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2026
CompletedFirst Submitted
Initial submission to the registry
April 24, 2026
CompletedFirst Posted
Study publicly available on registry
April 30, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
April 30, 2026
April 1, 2026
11 months
April 24, 2026
April 24, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Intraoperative diagnosis of inflammatory ureteral polyps
The primary outcome is the presence or absence of inflammatory ureteral polyps confirmed by intraoperative pathology or direct visualization during ureteroscopy.
At the time of ureteroscopic surgery
Study Arms (2)
Retrospective Cohort
This cohort includes patients with ureteral calculi who underwent treatment between 2018 and 2025 at the First Hospital of Jilin University. Clinical and imaging data will be analyzed to identify risk factors for inflammatory ureteral polyps.
Prospective Validation Cohort
This prospective cohort is currently recruiting patients with ureteral calculi to validate the predictive model developed from the retrospective data.
Eligibility Criteria
The study population includes adult patients with ureteral calculi who underwent ureteroscopic treatment at the First Hospital of Jilin University. The retrospective cohort includes patients treated between 2018 and 2025, and the prospective cohort is recruiting new patients for validation.
You may qualify if:
- Patients aged 18 years or older undergoing ureteroscopic surgery for ureteral calculi at the First Hospital of Jilin University.
- Complete clinical and imaging data available.
You may not qualify if:
- Patients with bilateral ureteral calculi.
- Patients with preoperative nephrostomy or indwelling ureteral stent.
- Patients with a history of ureteral or bladder cancer.
- Patients with congenital ureteral anomalies or previous ureteral surgery.
- Patients with severe coagulation disorders or contraindications to ureteroscopy.
- Patients unable to provide informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The First Hospital of Jilin University
Changchun, Jilin, 130021, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 24, 2026
First Posted
April 30, 2026
Study Start
March 1, 2026
Primary Completion (Estimated)
February 1, 2027
Study Completion (Estimated)
February 1, 2027
Last Updated
April 30, 2026
Record last verified: 2026-04